Effect of immunotherapy on overall survival in limited-stage small cell lung carcinoma: a national cancer database analysis.

Nadeem BilaniEvan AlleyLeah ElsonZeina NahlehRafael Arteta-Bulos

Published in: Therapeutic advances in medical oncology (2021)

In this study using a large national database, we found that the inclusion of immunotherapy as part of the initial systemic therapy regimen was not significantly associated with improved OS in a cohort of LS-SCLC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
single cell
prognostic factors
cell therapy
adverse drug
quality improvement
emergency department
electronic health record